Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

In a large, new, observational study, β-blocker treatment did not improve clinical outcomes in patients with coronary artery disease (CAD), including those with previous myocardial infarction, and was associated with more events in individuals with risk factors only. The role of β-blockers for secondary prevention in these patients should be reconsidered.

Citation

Nicolas Danchin, Stéphane Laurent. Coronary artery disease. Are β-blockers truly helpful in patients with CAD? Nature reviews. Cardiology. 2013 Jan;10(1):11-2

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 23149827

View Full Text